Newpath Partners, L.P. 13D/13G Filings for Prime Medicine, Inc. (PRME)

Newpath Partners, L.P. 13D and 13G filings for Prime Medicine, Inc.:

  • Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
  • Shares have been adjusted for stock splits.
Time period
Reported
DateTime		 Transaction
Date		 Type Company
Symbol		 Filed By
Symbol		 Shares Owned
% Owned		 Shares Vs. Prev Report View
2025-02-14
4:15 pm
Purchase		 2024-12-31 13G Prime Medicine, Inc.
PRME		 Newpath Partners, L.P. 6,105,679
4.700%		 800,000increase
(+15.08%)		 Filing
2023-02-07
4:46 pm
Purchase		 2022-12-31 13G Prime Medicine, Inc.
PRME		 Newpath Partners, L.P. 5,305,679
5.500%		 5,305,679increase
(New Position)		 Filing